Yew Bio-Pharm Group, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2018. For the quarter, total revenues were $3,031,138 against $7,875,464 a year ago. Income from operations was $219,423 against $221,577 a year ago. Income before provision for income taxes was $149,006 against $169,904 a year ago. Net income was $149,006 against $169,904 a year ago. Net cash provided by operating activities was $10,922,020 against cash used in operating activities of $2,611,802 a year ago. Purchase of land use rights and yew forest assets was $3,471,401.